Mylan

Mylan is a global pharmaceutical company that was first established in 1961. It is known for producing a wide range of generic and specialty medications. The company's headquarters are located in Canonsburg, Pennsylvania, United States.

History

Mylan was founded by Milan Puskar and Don Panoz in 1961 in White Sulphur Springs, West Virginia. The company initially operated as a distributor for vitamin products. In 1966, Mylan began manufacturing its own pharmaceutical products. The company went public in 1973 and has since grown to become one of the world's largest manufacturers of generic and specialty pharmaceuticals.

Products

Mylan's product portfolio includes a wide range of generic and specialty pharmaceuticals. The company produces medicines in several therapeutic areas, including cardiology, dermatology, oncology, neurology, and respiratory diseases. Some of the company's most well-known products include the EpiPen, a device used to treat severe allergic reactions, and a generic version of the HIV medication, Atripla.

Controversies

Mylan has been involved in several controversies over the years. In 2016, the company faced significant backlash over the pricing of its EpiPen product. The price of the EpiPen had increased by more than 500% over a period of several years, leading to accusations of price gouging. Mylan has also faced criticism for its tax practices, particularly its 2015 inversion to the Netherlands.

Future

Despite the controversies, Mylan continues to be a major player in the global pharmaceutical industry. In 2020, the company merged with Upjohn, a division of Pfizer, to form a new company called Viatris. Template:Pharmaceutical-company-stub